Medicare Advantage Organizations (MAO) sometimes inappropriately delay or deny beneficiaries’ access to medically necessary care, according to a recent OIG report. The OIG conducted a study and found that Medicare Advantage beneficiaries were denied access to services such as advanced imaging services and postacute facility stays.
CMS recently created a new Healthcare Common Procedure Coding System (HCPCS) code, J0248, for VEKLURY™ (remdesivir), an antiviral medication that is used to treat COVID-19.
The 2022 Medicare Physician Fee Schedule (MPFS) final rule ushers in significant changes to billing for split/shared visits, telehealth coverage, and more.
